Larry Biegelsen
Stock Analyst at Wells Fargo
(3.62)
# 847
Out of 4,996 analysts
331
Total ratings
51.48%
Success rate
5.74%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Overweight | $93 → $72 | $67.55 | +6.59% | 18 | Aug 28, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $100 | $94.22 | +6.13% | 18 | Aug 20, 2025 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $0.68 → $0.85 | $1.53 | -44.40% | 6 | Aug 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $20 → $13 | $12.00 | +8.33% | 10 | Aug 7, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $84 → $88 | $76.25 | +15.41% | 17 | Aug 7, 2025 | |
| ALC Alcon | Reinstates: Equal-Weight | $93 | $73.92 | +25.81% | 9 | Aug 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $174 → $101 | $77.24 | +30.76% | 13 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Overweight | $435 → $445 | $369.02 | +20.59% | 16 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $137 → $131 | $119.99 | +9.18% | 6 | Aug 1, 2025 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $6 → $3 | $1.74 | +72.41% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $21.98 | +9.19% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $86 → $92 | $79.92 | +15.12% | 15 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $15 | $14.50 | +3.45% | 7 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $108 → $100 | $80.20 | +24.69% | 11 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $253.37 | +14.46% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $12.89 | +12.49% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $124 | $98.18 | +26.30% | 14 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $559 → $599 | $441.12 | +35.79% | 20 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $24.33 | +10.97% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $9 | $9.03 | -0.33% | 14 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $98.24 | -0.24% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $89 | $72.46 | +22.83% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $10.20 | +66.67% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $179.71 | -15.42% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $67.10 | +40.09% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $13.20 | +271.21% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $133.55 | +1.83% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $55.70 | +25.67% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $184.60 | +46.26% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $50.61 | - | 2 | Nov 2, 2017 |
The Cooper Companies
Aug 28, 2025
Maintains: Overweight
Price Target: $93 → $72
Current: $67.55
Upside: +6.59%
Medtronic
Aug 20, 2025
Maintains: Overweight
Price Target: $98 → $100
Current: $94.22
Upside: +6.13%
Hyperfine
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.53
Upside: -44.40%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $20 → $13
Current: $12.00
Upside: +8.33%
Edwards Lifesciences
Aug 7, 2025
Maintains: Overweight
Price Target: $84 → $88
Current: $76.25
Upside: +15.41%
Alcon
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $73.92
Upside: +25.81%
Inspire Medical Systems
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $174 → $101
Current: $77.24
Upside: +30.76%
Stryker
Aug 1, 2025
Maintains: Overweight
Price Target: $435 → $445
Current: $369.02
Upside: +20.59%
Teleflex
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $137 → $131
Current: $119.99
Upside: +9.18%
Pulmonx
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.74
Upside: +72.41%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $21.98
Upside: +9.19%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $86 → $92
Current: $79.92
Upside: +15.12%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $12 → $15
Current: $14.50
Upside: +3.45%
Jul 31, 2025
Maintains: Overweight
Price Target: $108 → $100
Current: $80.20
Upside: +24.69%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $253.37
Upside: +14.46%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $12.89
Upside: +12.49%
Jul 24, 2025
Maintains: Overweight
Price Target: $118 → $124
Current: $98.18
Upside: +26.30%
Jul 23, 2025
Maintains: Overweight
Price Target: $559 → $599
Current: $441.12
Upside: +35.79%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $24.33
Upside: +10.97%
Jul 9, 2025
Downgrades: Equal-Weight
Price Target: $25 → $9
Current: $9.03
Upside: -0.33%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $98.24
Upside: -0.24%
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $72.46
Upside: +22.83%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $10.20
Upside: +66.67%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $179.71
Upside: -15.42%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $67.10
Upside: +40.09%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $13.20
Upside: +271.21%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $133.55
Upside: +1.83%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $55.70
Upside: +25.67%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $184.60
Upside: +46.26%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $50.61
Upside: -